Anthropic says AI development may need to slow as systems approach recursive self-improvement. The company proposes global ...
The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...
Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...
Suchandrima Bhowmik has written over 300 articles on various health conditions, medical news, and recent breakthroughs. Her work appears in several publications, including Medical News Today, ...
Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...
Microsoft Excel remains a cornerstone for data analysts, offering a wide array of functions to streamline workflows and enhance data accuracy. In this deep dive, Mo Chen highlights ten essential Excel ...
I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Recursion (RXRX). The reason why I want to go over this biotech next is because the company ...
What if you could save hours on your Excel tasks while uncovering insights hidden deep within your data? My Online Training Hub explains how modern Excel functions are transforming data analysis in ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A closeup shot of a laboratory worker arranging pipette tips in a blue container for a ...
One reason Recursion Pharmaceuticals could become a big deal is that its goal is to usher a paradigm shift into the pharmaceutical industry. Even with impressive technological progress over the past ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — In the year-plus since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results